Corporate Publications
Explore ANSTO's range of publications and reports available for the public.
Showing 61 - 80 of 658 results
Explore ANSTO's range of publications and reports available for the public.
Tool developed for producing F-18 radiopharmaceuticals for PET imaging.
In 2017, ANSTO's CEO signed a Memorandum of Understanding with Sri Lanka to work together to investigate the epidemiology of Chronic Kidney Disease of unknown origin (CKDu).
ANSTO plays a leading role in measuring and characterising fine particles from a range of locations around Australia and internationally.
Dr Meng Jun Qin is a materials scientist with expertise in computer modelling
ANSTO Nuclear Fuel Cycle researcher recognised for contributions to crystallography and structural chemistry on actinides and lanthanides.
On behalf of ANSTO thank you for your interest in our tours. We hope your visit to ANSTO will be both enjoyable and informative.
Applications, Recent results, Publications.
The IAEA is providing $1.3m over four years to implement a new, Australian-led patient-care project for the Asia and Pacific region
Under section 35 of the Public Governance, Performance and Accountability Act 2013, all Commonwealth Government bodies are required to annually prepare a Corporate Plan, which must be published on their websites by 31 August.
ANSTO addresses key scientific questions in the nuclear fuel cycle for both the current generation of nuclear reactors and future systems.
ANSTO is dedicated to identifying opportunities for the application of knowledge and technology developed by the organisation for a wide range of industry applications.
The analytical power of non-destructive X-ray fluorescence microscopy (XFM) at the Australian Synchrotron has been highlighted in a book chapter in Giorgione, Dante and the Sydney Incunable that features its use on an historic Renaissance work, Dante’s Commedia.